Kanclerz A, Chapman J D
Br J Cancer. 1986 Oct;54(4):693-8. doi: 10.1038/bjc.1986.228.
4-Hydroxyanisole (4-OHA) was administered to C57Bl/10J mice in which B16 melanoma or Lewis lung carcinoma had been implanted s.c. or i.m. The drug had the largest antitumour effect against B16 melanoma growing s.c. and a smaller antitumour effect against B16 melanoma or Lewis lung carcinoma growing i.m. In the treatment regimens where drug was administered only after tumour implantation, a significant reduction in number of spontaneous metastases and their incidence was observed. Again, the largest antimetastatic effect was observed for s.c. B16 melanoma with smaller effects observed for i.m. B16 melanoma or Lewis lung carcinoma. Experiments in which 4-OHA treatment was initiated after amputation of the primary tumour implanted in the tail confirmed that 4-OHA did have antitumour activity against disseminated tumour cells. The drug regimens studied to date produced significant delays in the appearance of spontaneous metastases in the lungs and significant increases in the life spans of the treated animals.
将4-羟基茴香醚(4-OHA)给予已皮下或肌肉注射植入B16黑色素瘤或Lewis肺癌的C57Bl/10J小鼠。该药物对皮下生长的B16黑色素瘤具有最大的抗肿瘤作用,而对肌肉注射生长的B16黑色素瘤或Lewis肺癌的抗肿瘤作用较小。在仅在肿瘤植入后给药的治疗方案中,观察到自发转移灶数量及其发生率显著降低。同样,皮下B16黑色素瘤的抗转移作用最大,肌肉注射B16黑色素瘤或Lewis肺癌的抗转移作用较小。对植入尾部的原发性肿瘤截肢后开始4-OHA治疗的实验证实,4-OHA确实对播散的肿瘤细胞具有抗肿瘤活性。迄今为止研究的药物方案显著延迟了肺部自发转移灶的出现,并显著延长了治疗动物的寿命。